SLC16A11 and neoplasm: The MCT11 blockade required the presence of an adaptive immune response, as αMCT11 had no effect in Rag-deficient mice (Fig. 4h–k) and also suggested αMCT11 therapy’s effect was not due to blockade of MCT11 on B16 or MEER tumor cells themselves.